Lars Weiss

1.5k total citations
28 papers, 1.0k citations indexed

About

Lars Weiss is a scholar working on Nephrology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lars Weiss has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 12 papers in Surgery and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lars Weiss's work include Lipoproteins and Cardiovascular Health (10 papers), Dialysis and Renal Disease Management (9 papers) and Chronic Kidney Disease and Diabetes (5 papers). Lars Weiss is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Dialysis and Renal Disease Management (9 papers) and Chronic Kidney Disease and Diabetes (5 papers). Lars Weiss collaborates with scholars based in Sweden, United States and Netherlands. Lars Weiss's co-authors include Ola Samuelsson, Carolyn Knight‐Gibson, H. Mulec, Petar Alaupovic, P.-O. Attman, Robert Larsson, B Kron, Hans Wedel, Ole Simonsen and Anders Christensson and has published in prestigious journals such as Kidney International, Journal of Clinical Microbiology and Hypertension.

In The Last Decade

Lars Weiss

28 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Weiss Sweden 17 633 398 256 163 121 28 1.0k
Erwin H. Fleischmann Germany 14 420 0.7× 245 0.6× 213 0.8× 280 1.7× 71 0.6× 19 884
D C Cattran Canada 16 556 0.9× 207 0.5× 149 0.6× 71 0.4× 88 0.7× 31 1.0k
Vladimı́r Teplan Czechia 22 642 1.0× 200 0.5× 183 0.7× 246 1.5× 177 1.5× 85 1.5k
José Manuel González‐Posada Spain 21 541 0.9× 373 0.9× 118 0.5× 107 0.7× 74 0.6× 46 1.3k
Ho Yung Lee South Korea 20 902 1.4× 333 0.8× 68 0.3× 108 0.7× 83 0.7× 42 1.2k
P Rindi Italy 13 510 0.8× 269 0.7× 56 0.2× 156 1.0× 79 0.7× 41 880
Francesco Locatelli Italy 4 434 0.7× 97 0.2× 228 0.9× 143 0.9× 165 1.4× 5 844
Soraya Abad Spain 17 495 0.8× 261 0.7× 62 0.2× 158 1.0× 89 0.7× 65 870
Jörg H. Horina Austria 16 312 0.5× 160 0.4× 69 0.3× 77 0.5× 43 0.4× 30 732
Soon Bae Kim South Korea 13 291 0.5× 207 0.5× 62 0.2× 75 0.5× 65 0.5× 25 614

Countries citing papers authored by Lars Weiss

Since Specialization
Citations

This map shows the geographic impact of Lars Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Weiss more than expected).

Fields of papers citing papers by Lars Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Weiss. The network helps show where Lars Weiss may publish in the future.

Co-authorship network of co-authors of Lars Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Weiss. A scholar is included among the top collaborators of Lars Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Weiss. Lars Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernström, Anders, Britta Hylander, Gert Jensen, et al.. (2011). Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: An observational study. Scandinavian Journal of Urology and Nephrology. 45(3). 196–205. 6 indexed citations
2.
Wahlstrand, Björn, Peter Almgren, Stanko Skrtic, et al.. (2008). Interaction Between Renal Function and Microalbuminuria for Cardiovascular Risk in Hypertension. Hypertension. 52(1). 115–122. 38 indexed citations
3.
Alaupovic, Petar, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (2006). Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency. Kidney International. 69(10). 1865–1871. 18 indexed citations
4.
Jönsson, Linus, George W. Carides, Thomas Burke, et al.. (2005). Cost-effective prevention of renal failure in type 2 diabetics using losartan. Journal of Medical Economics. 8(1-4). 131–138. 4 indexed citations
5.
Cederholm, Jan, Björn Eliasson, Per-Erik Nilsson, Lars Weiss, & Soffia Guðbjörnsdóttir. (2004). Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Research and Clinical Practice. 67(3). 258–266. 59 indexed citations
6.
Samuelsson, Ola, Per‐Ola Attman, Carolyn Knight‐Gibson, et al.. (2002). Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency. American Journal of Kidney Diseases. 39(1). 67–75. 27 indexed citations
7.
Attman, Per-Ola, et al.. (2001). Do High-flux Dialysis Membranes Affect Renal Dyslipidemia?. ASAIO Journal. 47(3). 229–234. 13 indexed citations
8.
Rippe, Bengt, Ole Simonsen, Olof Heimbürger, et al.. (2001). Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney International. 59(1). 348–357. 197 indexed citations
9.
Weiss, Lars. (2001). Flexible dosing schemes for recombinant human erythropoietin--lessons from our daily practice. Nephrology Dialysis Transplantation. 16(suppl 7). 15–19. 4 indexed citations
10.
Weiss, Lars, et al.. (2000). The efficacy of once weekly compared with two or three times weekly subcutaneous epoetin β: results from a randomized controlled multicentre trial. Nephrology Dialysis Transplantation. 15(12). 2014–2019. 60 indexed citations
11.
Samuelsson, Ola, Per‐Ola Attman, Rutger Larsson, et al.. (2000). Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease. Nephrology Dialysis Transplantation. 15(4). 481–486. 20 indexed citations
12.
Attman, Per-Ola, Ola Samuelsson, James B. Moberly, et al.. (1999). Apolipoprotein B-containing lipoproteins in renal failure: The relation to mode of dialysis. Kidney International. 55(4). 1536–1542. 60 indexed citations
13.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1999). The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression. ˜The œNephron journals/Nephron journals. 82(4). 306–311. 26 indexed citations
14.
Samuelsson, Ola, H. Mulec, Carolyn Knight‐Gibson, et al.. (1997). Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrology Dialysis Transplantation. 12(9). 1908–1915. 179 indexed citations
15.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1997). Effect of Gemfibrozil on Lipoprotein Abnormalities in Chronic Renal Insufficiency: A Controlled Study in Human Chronic Renal Disease. Nephron. 75(3). 286–294. 21 indexed citations
16.
Samuelsson, Ola, P.-O. Attman, Carolyn Knight‐Gibson, et al.. (1996). Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure. Nephrology Dialysis Transplantation. 11(11). 2237–2243. 14 indexed citations
17.
Ljunghall, Sver­ker, et al.. (1990). Effects on Serum Parathyroid Hormone of Intravenous Treatment with Alphacalcidol in Patients on Chronic Hemodialysis. ˜The œNephron journals/Nephron journals. 55(4). 380–385. 8 indexed citations
18.
Weiss, Lars, et al.. (1989). Aluminum Removal with Hemodialysis, Hemofiltration and Charcoal Hemoperfusion in Uremic Patients after Desferrioxamine Infusion. ˜The œNephron journals/Nephron journals. 51(3). 325–329. 11 indexed citations
19.
Danielson, B. G., Bengt Fellström, Per Nilsson, Lars Weiss, & Björn Wíkström. (1986). TRACE ELEMENT LEVELS IN PATIENTS WITH RENAL FAILURE AND AFTER TRANSPLANTATION. Acta Pharmacologica et Toxicologica. 59(s7). 438–441. 8 indexed citations
20.
Danielson, Bo G., et al.. (1984). Enalapril Treatment in a Patient With Impaired Renal Function and Intolerance to Captopril. Scandinavian Journal of Urology and Nephrology. 18(sup79). 99–102. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erwin H. Fleischmann Breakdown of academic impact, for papers by D C Cattran Breakdown of academic impact, for papers by Vladimı́r Teplan Breakdown of academic impact, for papers by José Manuel González‐Posada Breakdown of academic impact, for papers by Ho Yung Lee Breakdown of academic impact, for papers by P Rindi Breakdown of academic impact, for papers by Francesco Locatelli Breakdown of academic impact, for papers by Soraya Abad Breakdown of academic impact, for papers by Jörg H. Horina Breakdown of academic impact, for papers by Soon Bae Kim
Rankless by CCL
2026